BioXcel Therapeutics (BTAI) Institutional Ownership $0.34 +0.03 (+8.12%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for BioXcel Therapeutics (NASDAQ:BTAI)CurrentInstitutional OwnershipPercentage30.68%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$4.04MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$420.20K Get BTAI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTAI Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. BioXcel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC49,317$30K0.0%-60.6%0.121% 11/15/2024 State Street Corp77,149$47K0.0%-38.2%0.189% 11/13/2024 BNP Paribas Financial Markets44,381$27K0.0%-83.8%0.109% 9/16/2024 Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081% 8/15/2024 Armistice Capital LLC2,987,000$3.82M0.0%+705.2%7.959% 8/15/2024 Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081% Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2024 XTX Topco Ltd46,503$60K0.0%+49.0%0.124% 7/12/2024 Rosalind Advisors Inc.39,672$51K0.0%N/A0.106% 5/20/2024 Virtu Financial LLC13,990$39K0.0%-76.5%0.037% 5/10/2024 Vanguard Group Inc.1,099,375$3.10M0.0%+0.9%2.968% 2/26/2024 Virtu Financial LLC59,514$176K0.0%N/A0.196% 2/14/2024 Pennant Investors LP83,900$248K0.1%N/A0.276% 2/13/2024 Tower Research Capital LLC TRC13,832$41K0.0%+239.2%0.046% 2/6/2024 Apollon Wealth Management LLC10,537$31K0.0%N/A0.035% 2/2/2024 Truist Financial Corp10,879$32K0.0%N/A0.036% 1/23/2024 DAVENPORT & Co LLC35,385$104K0.0%-42.5%0.118% 12/6/2023 Citigroup Inc.24,336$62K0.0%-59.5%0.083% 11/15/2023 Adage Capital Partners GP L.L.C.200,000$506K0.0%-89.8%0.683% 11/13/2023 FMR LLC2,700,727$6.83M0.0%-38.2%9.227% 10/27/2023 Hennion & Walsh Asset Management Inc.33,940$86K0.0%+89.5%0.116% 10/24/2023 Bank of New York Mellon Corp128,022$324K0.0%+13.2%0.437% 10/12/2023 SeaCrest Wealth Management LLC16,550$42K0.0%-20.0%0.057% 8/14/2023 Driehaus Capital Management LLC22,220$148K0.0%-94.3%0.076% 8/11/2023 E Fund Management Co. Ltd.10,628$71K0.0%N/A0.036% 8/10/2023 Profund Advisors LLC35,475$236K0.0%+29.2%0.122% 8/10/2023 US Bancorp DE14,072$94K0.0%+42,542.4%0.048% 8/9/2023 BNP Paribas Arbitrage SNC69,994$466K0.0%-38.5%0.240% 7/25/2023Raymond James & Associates18,648$124K0.0%+32.7%0.064% 7/20/2023 DAVENPORT & Co LLC59,705$398K0.0%-25.6%0.205% 7/19/2023 Artemis Investment Management LLP895,048$5.96M0.1%-8.8%3.069% 7/14/2023 SeaCrest Wealth Management LLC20,700$138K0.0%+38.9%0.071% 5/12/2023 AlphaCentric Advisors LLC40,000$746K0.5%-20.0%0.138% 5/12/2023 SeaCrest Wealth Management LLC14,907$278K0.0%N/A0.051% 5/12/2023 Profund Advisors LLC27,462$512K0.0%N/A0.095% 5/11/2023 FMR LLC4,276,693$79.80M0.0%+1.7%14.742% 5/11/2023 Citigroup Inc.118,975$2.22M0.0%+19,120.5%0.410% 5/10/2023 Tocqueville Asset Management L.P.37,000$690K0.0%-6.1%0.128% 5/8/2023 Federated Hermes Inc.61,730$1.15M0.0%N/A0.213% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank12,103$226K0.0%+8.2%0.042% 5/5/2023 Truist Financial Corp11,353$212K0.0%-4.9%0.039% URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now5/5/2023 Artemis Investment Management LLP981,472$18.28M0.2%-26.4%3.383% 5/4/2023 Barclays PLC56,023$1.05M0.0%+990.8%0.193% 5/4/2023 Mirae Asset Global Investments Co. Ltd.14,137$264K0.0%N/A0.049% 4/27/2023 DAVENPORT & Co LLC80,295$1.50M0.0%-48.9%0.277% 4/21/2023 Capital Investment Advisory Services LLC17,325$323K0.0%N/A0.060% 4/20/2023 Hennion & Walsh Asset Management Inc.37,887$707K0.0%-3.3%0.131% 4/14/2023Raymond James & Associates14,052$262K0.0%-11.8%0.048% 4/13/2023 Allspring Global Investments Holdings LLC49,311$920K0.0%N/A0.170% 2/14/2023 Driehaus Capital Management LLC505,934$10.87M0.2%N/A1.806% 2/10/2023 Sectoral Asset Management Inc.61,156$1.31M0.3%N/A0.218% 2/9/2023 Tocqueville Asset Management L.P.39,400$846K0.0%+37.5%0.141% 2/8/2023 UBS Group AG139,214$2.99M0.0%-2.9%0.497% 2/1/2023 Zurcher Kantonalbank Zurich Cantonalbank11,182$240K0.0%+50.0%0.040% 1/25/2023 Artemis Investment Management LLP1,333,691$28.75M0.3%-3.0%4.760% 1/20/2023 DAVENPORT & Co LLC157,105$3.38M0.0%+44.7%0.561% 1/12/2023 Hennion & Walsh Asset Management Inc.39,185$842K0.1%+14.5%0.140% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.17,452$206K0.0%N/A0.062% 11/10/2022 UBS Group AG143,388$1.70M0.0%+22.5%0.512% 11/9/2022 Massachusetts Financial Services Co. MA453,877$5.37M0.0%+7.3%1.620% 11/8/2022 AlphaCentric Advisors LLC50,000$591K0.6%N/A0.178% 11/7/2022 Quantbot Technologies LP4,879$57K0.0%N/A0.017% 11/7/2022 Jump Financial LLC26,000$307K0.0%+22.2%0.093% 10/26/2022 Truist Financial Corp23,307$275K0.0%+16.7%0.083% 10/25/2022 Artemis Investment Management LLP1,374,496$16.26M0.2%-0.8%4.905% 10/13/2022 PVG Asset Management Corp15,040$178K0.7%N/A0.054% 10/11/2022 DAVENPORT & Co LLC108,545$1.28M0.0%+26.7%0.387% 8/13/2022 Massachusetts Financial Services Co. MA423,021$5.58M0.0%-0.7%1.511% 8/12/2022 Virtus ETF Advisers LLC11,284$149K0.1%+46.3%0.040% 8/11/2022 Alps Advisors Inc.16,596$219K0.0%-42.3%0.059% 8/8/2022 Walleye Capital LLC36,896$487K0.0%N/A0.132% 8/5/2022 State Board of Administration of Florida Retirement System17,112$226K0.0%+45.0%0.061% 8/4/2022 Game Plan Financial Advisors LLC10,880$142K0.1%N/A0.039% 7/29/2022 SG Americas Securities LLC43,468$574K0.0%N/A0.155% 7/29/2022 Crossmark Global Holdings Inc.12,083$159K0.0%N/A0.043% 7/22/2022 Truist Financial Corp19,974$264K0.0%+3.6%0.071% 7/22/2022 Artemis Investment Management LLP1,384,938$18.31M0.2%-3.0%4.948% 7/18/2022 DAVENPORT & Co LLC85,670$1.13M0.0%+154.3%0.306% 6/30/2022 Amalgamated Bank2,816$59K0.0%N/A0.010% 5/17/2022 HITE Hedge Asset Management LLC12,768$267K0.0%-22.1%0.046% 5/13/2022 Apis Capital Advisors LLC40,000$836K1.0%N/A0.143% 5/11/2022 Massachusetts Financial Services Co. MA426,177$8.91M0.0%+2.8%1.523% 5/2/2022 DAVENPORT & Co LLC33,682$704K0.0%-2.9%0.120% 4/29/2022 Nisa Investment Advisors LLC12,600$263K0.0%N/A0.045% 4/26/2022 Hennion & Walsh Asset Management Inc.35,221$736K0.0%+2.1%0.126% 4/22/2022 Truist Financial Corp19,280$403K0.0%N/A0.069% 4/21/2022 Artemis Investment Management LLP1,428,228$29.86M0.2%+1.3%5.104% 2/25/2022 AlphaCentric Advisors LLC50,000$1.02M0.3%N/A0.179% 2/14/2022 Virtus ETF Advisers LLC8,164$166K0.1%+47.1%0.029% 2/14/2022 Alliancebernstein L.P.1,508,768$30.67M0.0%+47.9%5.392% 2/11/2022 CNA Financial Corp14,359$292K0.1%+42.5%0.051% URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now2/11/2022 Ensign Peak Advisors Inc5,400$110K0.0%N/A0.019% 2/10/2022 Rafferty Asset Management LLC98,638$2.01M0.0%+64.9%0.353% 2/10/2022 Citigroup Inc.77,552$1.58M0.0%+97.0%0.277% 2/10/2022 Massachusetts Financial Services Co. MA414,484$8.43M0.0%-0.7%1.481% 2/10/2022 WINTON GROUP Ltd12,260$249K0.0%N/A0.044% 2/9/2022 BNP Paribas Arbitrage SA66,834$1.36M0.0%+164.4%0.239% 2/9/2022 Alps Advisors Inc.32,375$658K0.0%-5.6%0.116% 2/8/2022 Artemis Investment Management LLP1,410,382$28.60M0.2%+2.2%5.041% 2/8/2022 Bank of America Corp DE140,985$2.87M0.0%+121.3%0.504% 2/8/2022 Northern Trust Corp193,307$3.93M0.0%+1.7%0.691% (Data available from 1/1/2016 forward) BTAI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTAI shares? During the previous two years, 37 institutional investors and hedge funds held shares of BioXcel Therapeutics. The most heavily invested institutionals were FMR LLC ($6.83M), Artemis Investment Management LLP ($5.96M), Armistice Capital LLC ($3.82M), Vanguard Group Inc. ($3.10M), UBS Group AG ($2.99M), Sectoral Asset Management Inc. ($1.31M), and Federated Hermes Inc. ($1.15M).Learn more on BTAI's institutional investors. What percentage of BioXcel Therapeutics stock is owned by institutional investors? 30.68% of BioXcel Therapeutics stock is owned by institutional investors. Learn more on BTAI's institutional investor holdings. Which institutional investors have been buying BioXcel Therapeutics stock? Of the 29 institutional investors that purchased BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.62M), Driehaus Capital Management LLC ($505.93K), Citigroup Inc. ($118.36K), Pennant Investors LP ($83.90K), FMR LLC ($73.26K), Federated Hermes Inc. ($61.73K), and Sectoral Asset Management Inc. ($61.16K). How much institutional buying is happening at BioXcel Therapeutics? Institutional investors have bought a total of 4,053,451 shares in the last 24 months. This purchase volume represents approximately $26.04M in transactions. Which BioXcel Therapeutics major shareholders have been selling company stock? Of the 18 institutional investors that sold BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.75M), FMR LLC ($1.67M), Artemis Investment Management LLP ($479.45K), Driehaus Capital Management LLC ($366.55K), BNP Paribas Financial Markets ($228.75K), DAVENPORT & Co LLC ($123.52K), and Jane Street Group LLC ($75.73K). How much institutional selling is happening at BioXcel Therapeutics? Institutional investors have sold a total of 4,896,323 shares in the last 24 months. This volume of shares sold represents approximately $21.91M in transactions. Related Companies Connect Biopharma Major Shareholders Spero Therapeutics Major Shareholders Aadi Bioscience Major Shareholders Mural Oncology Major Shareholders Invivyd Major Shareholders Kronos Bio Major Shareholders Immix Biopharma Major Shareholders Immuneering Major Shareholders Shattuck Labs Major Shareholders AlloVir Major Shareholders This page (NASDAQ:BTAI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.